A study found a surprising link between aspirin in the elderly and cancer mortality[1]. Low-dose aspirin was not associated with reduced cancer incidence in older adults[1]. On the contrary, they were associated with an increased risk of death from cancer[1]. It is a cohort study of participants from the ASPREE randomized trial[1]. Daily low-dose aspirin led to an increase in cancer mortality in elderly subjects during the study period[1]. The results show a higher probability of cancer at an advanced stage when taking aspirin[1]. In elderly and otherwise healthy individuals, aspirin worsened the condition in case of cancer[1].